Drug intelligence / Profile preview

chloroxine

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral
01

Overview

Chloroxine is a synthetic antibacterial compound and quinoline derivative used primarily for the treatment of dandruff and mild to moderately severe seborrheic dermatitis of the scalp. It is available in topical formulations such as shampoos (e.g., Capitrol) and creams (e.g., Valpeda, Triaderm), as well as oral formulations (notably under the brand name Endiaron) for infectious diarrhea and disorders of intestinal microflora. Chloroxine exhibits bacteriostatic, fungistatic, and antiprotozoal properties; it is effective against Streptococci, Staphylococci, Candida species (including C. albicans), Shigella species, and Trichomonads. The precise mechanism of action is not fully understood but may involve inhibition of mitotic activity in the epidermis to reduce excessive scaling or induction of genotoxic effects in bacteria via SOS-DNA repair pathways[1][4][5][7]. Chloroxine was first synthesized in 1888.

Brand names
CapitrolEndiaronValpedaTriaderm
Other names
cloroxinumkloroxindichlorchinolinolumchlorquinolhalquinol
02

Targets

Neuraminidase

Beyond the preview

Go deeper on chloroxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chloroxine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call